| ST000852 Targeting Myelin Galactosyl Sphingolipids of Kallikrein 6 Signals through PAR1 and PAR2 to Enchance Recovery of Function after SCI | ||||
| Limit by pathway class: | ||||
| Pathway name (# of metabolites detected in this study) | HMDB pathway | KEGG pathway |
|---|---|---|
| Sphingolipid Metabolism (3) | SMP0000034 | map00600 |
